KATHERINE CARVELL: Open Payments
NPI 1962997106 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 72 payments from 19 companies in 2025. Trend: 2023 $1,520 · 2024 $1,129 · 2025 $1,223
Food & beverage: $1,169Education: $54
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $234 |
| Novartis Pharmaceuticals Corporation | 16 | $206 |
| Medtronic, Inc. | 11 | $180 |
| Amgen Inc. | 7 | $127 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| Novo Nordisk Inc | 3 | $50 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| BridgeBio Pharma, Inc. | 2 | $41 |
| Ethicon US, LLC | 1 | $34 |
| Philips North America LLC | 1 | $33 |
Products named: LEQVIO, ELIQUIS, REPATHA, AURORA EV-ICD MRI SURESCAN, VYNDAQEL, AMVUTTRA, VERQUVO, Attruby.
Industry payments across ND — which companies pay providers there.
